BeStock  
Stocks › Biotechnology › TRVI

Trevi Therapeutics TRVI

US equityMarket cap rank #2802Biotechnology
$13.72 −$0.19 (-1.37%)
Pre-market · Oct 6, 4:10 am ET · After hours $13.72 0.00%
Open$13.97
Prev close$13.91
Day range$13.51 – $14.11
Volume1.72M
Market cap$1.95B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.

Technical signals

Trend readStrong downtrend

1 bullish · 5 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-8.5%BearishTrading below the 20-day average of $15.00
Price vs 50-day average-18.2%BearishTrading below the 50-day average of $16.78
Price vs 200-day average-3.9%BearishTrading below the 200-day average of $14.27
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)24.6NeutralOversold territory (30 or below); selling this heavy often eases
MACD (12,26,9)-0.81BearishMACD line is below its signal line
Bollinger band position13%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$15.00-8.5%
50-day SMA$16.78-18.2%
200-day SMA$14.27-3.9%

Recent price levels

LevelPrice
20-day high$17.18
20-day low$13.51
60-day high$20.22
60-day low$13.51
Upper Bollinger band$16.71
Lower Bollinger band$13.29

The 50-day average is currently 17.6% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility35.1%
Average true range4.18% of price
Max drawdown (1y)-29.6%
Volume (10d vs 90d)0.96x

Discussion

No comments yet — be the first to weigh in on TRVI.

Leave a comment

Scroll to Top